Clinical Trial Update: Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly Patients [Phase 2]

View source ↗

Summary

Phase 2 feasibility trial evaluating chemotherapy with docetaxel and prednisone for elderly patients with castration-resistant metastatic prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Docetaxel + Prednisone (docetaxel and prednisone)

Snippet

Sponsor: UNICANCER | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED